Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Z T, Fidarova"'
Autor:
A. V. Luchkin, E. A. Mikhailova, I. V. Galtseva, Z. T. Fidarova, A. V. Abramova, Yu. O. Davydova, N. M. Kapranov, K. A. Nikiforova, Yu. A. Tsoy, S. M. Kulikov, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 61-67 (2024)
Background. Acquired aplastic anemia (AA) is a non-tumor disease of the blood system and the pathogenesis is based on immune dysregulation directed against own hematopoietic stem cells, which leads to the development of bone marrow aplasia. Some mode
Externí odkaz:
https://doaj.org/article/4f7be53070e84dab992aeb1e23042f30
Autor:
A. V. Abramova, E. A. Mikhailova, I. V. Galtseva, Z. T. Fidarova, A. V. Luchkin, N. M. Kapranov, Yu. O. Davydova, S. M. Kulikov, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 159-172 (2024)
Background. Aplastic anemia (AA) is a non-tumor and rare disease of the blood system, characterized by deep pancytopenia due to the development of bone marrow aplasia with immune-mediated damage of hematopoietic stem cells. Research results indicate
Externí odkaz:
https://doaj.org/article/6ae7e02ccac14db383e9da874da659fb
Autor:
E. I. Zakharko, V. N. Dvirnyk, Yu. A. Chabaeva, D. G. Drokova, E. B. Rybkina, K. A. Lavrishinets, A. V. Bulgakov, M. N. Panasenko, Z. T. Fidarova, I. A. Lukianova, O. A. Aleshina, S. M. Kulikov, T. V. Gaponova, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 34-45 (2024)
Background. Vascular endothelial growth factor A (VEGFA) is one of the most important factors for regulation of hematopoietic stem cells differentiation. It is involved in leukemogenesis and central nervous system (CNS) damage in acute leukemia. Acco
Externí odkaz:
https://doaj.org/article/55d39ee6b6134f1db6b448704192c604
Autor:
V. D. Latyshev, Z. T. Fidarova, R. V. Ponomarev, N. V. Tsvetaeva, E. A. Mikhaylova, E. A. Lukina, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 1, Pp 83-91 (2024)
Background. Paroxysmal nocturnal hemoglobinuria is a rare clonal disease of the hematopoietic system, with the key manifestations of hemolytic anemia, a high thrombosis rate, and bone marrow failure. Despite the high efficacy of C5‑inhibitors in in
Externí odkaz:
https://doaj.org/article/719811036e4c4f839846b9282e0ac275
Autor:
A. V. Luchkin, E. A. Mikhailova, I. V. Galtseva, Z. T. Fidarova, A. V. Abramova, Yu. O. Davydova, N. M. Kapranov, K. A. Nikiforova, S. M. Kulikov, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 57-64 (2023)
Background. Aplastic anemia proceeds with bone marrow failure and is associated with immunological suppression of normal blood stem cells’ proliferation, which lead to bone marrow aplasia. autoimmune aggression and internal defects of blood stem ce
Externí odkaz:
https://doaj.org/article/03bcfe44c4a34087ae5ee470d71b9d44
Autor:
A. D. Kulagin, E. A. Lukina, V. V. Ptushkin, M. P. Kostinov, E. G. Arshanskaya, T. N. Babaeva, T. I. Ksenzova, Z. T. Fidarova, M. V. Marchenko
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 140-144 (2023)
On June 24, 2023, an Expert Council was held in St. Petersburg, during which leading experts in the field of hematology discussed current achievements and answered a number of unresolved issues of targeted therapy of paroxysmal nocturnal hemoglobinur
Externí odkaz:
https://doaj.org/article/7a0ccf75cd9245f48e4ac2e80b45a701
Autor:
E. S. Kotova, O. A. Gavrilina, I. A. Yakutik, A. B. Sudarikov, Yu. A. Chabaeva, S. M. Kulikov, S. G. Beksaev, V. V. Troitskaya, G. A. Isinova, A. N. Sokolov, Z. T. Fidarova, I. A. Lukyanova, A. V. Abramova, V. N. Dvirnyk, I. V. Galtseva, T. N. Obukhova, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 98-107 (2022)
Background. 6-mercaptopurine (6-MP) is a drug that is included in the treatment protocols for children and adults with acute lymphoblastic leukemias/lymphomas (ALL/LBL). It is known that individual differences in 6-MP tolerance can be explained by th
Externí odkaz:
https://doaj.org/article/258f0daa502345c7a75d1d9529faa844
Autor:
E. A. Mikhaylova, Z. T. Fidarova, A. V. Abramova, A. V. Luchkin, V. V. Troitskaya, V. N. Dvirnyk, I. V. Galtseva, G. A. Kliasova, A. M. Kovrigina, S. M. Kulikov, Yu. А. Chabaeva, E. N. Parovichnikova, V. G. Savchenko, T. N. Obukhova
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 4-9 (2020)
Treatment programs for patients with acquired aplastic anemia include two main therapeutic options: allogeneic bone marrow transplantation and combined immunosuppressive therapy (IST). However, combined IST remains the method of choice for most adult
Externí odkaz:
https://doaj.org/article/574dc4370279402b82bb06755b177aa5
Autor:
A. F. Rakhmani, E. A. Mikhaylova, I. V. Galtseva, Yu. O. Davidova, N. M. Kapranov, I. V. Dubinkin, S. M. Kulikov, T. V. Gaponova, Z. T. Fidarova, V. V. Troitskaya, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 14, Iss 3, Pp 38-51 (2019)
Background. In addition to anti-HLA-I and anti-HPA-antibodies and specific cytotoxic T-lymphocytes, another cause of immune refractoriness to donor's platelet transfusions could be a platelet-associated different classes immunoglobulins PAIg (G, M, A
Externí odkaz:
https://doaj.org/article/f06c240670f8441c81ff494ce12bc8ad
Autor:
A V Bazhenov, G M Galstyan, E N Parovichnikova, V V Troitskaya, L A Kuzmina, Z T Fidarova, E O Gribanova, S A Makhinya, O A Latyshkevich, U A Chabaeva, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 14-24 (2019)
Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts). We evaluate influence of transfer to ICU and life threatening complication on early mortali
Externí odkaz:
https://doaj.org/article/0f9fa6f9da044e4fb6fbb3950117b512